| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | clathrin light chain binding | 2.66e-04 | 7 | 72 | 2 | GO:0032051 | |
| GeneOntologyMolecularFunction | G protein-coupled acetylcholine receptor activity | 2.66e-04 | 7 | 72 | 2 | GO:0016907 | |
| Domain | Clathrin_H-chain_propeller_rpt | 1.35e-05 | 2 | 69 | 2 | IPR022365 | |
| Domain | Clathrin-link | 1.35e-05 | 2 | 69 | 2 | PF09268 | |
| Domain | - | 1.35e-05 | 2 | 69 | 2 | 2.130.10.110 | |
| Domain | Clathrin_H-chain_link/propller | 1.35e-05 | 2 | 69 | 2 | IPR016025 | |
| Domain | Clathrin_propel | 1.35e-05 | 2 | 69 | 2 | PF01394 | |
| Domain | Clathrin_heavy_chain | 1.35e-05 | 2 | 69 | 2 | IPR016341 | |
| Domain | Clathrin_H-chain_linker_core | 1.35e-05 | 2 | 69 | 2 | IPR015348 | |
| Domain | Clathrin_H-chain_propeller_N | 1.35e-05 | 2 | 69 | 2 | IPR001473 | |
| Domain | ARM-type_fold | 3.46e-05 | 339 | 69 | 8 | IPR016024 | |
| Domain | Clathrin_H-chain_linker | 4.03e-05 | 3 | 69 | 2 | IPR012331 | |
| Domain | CLH | 4.03e-05 | 3 | 69 | 2 | SM00299 | |
| Domain | Pyridoxal-P_BS | 1.34e-04 | 5 | 69 | 2 | IPR021115 | |
| Domain | Musac_Ach_rcpt | 1.34e-04 | 5 | 69 | 2 | IPR000995 | |
| Domain | Clathrin | 2.79e-04 | 7 | 69 | 2 | PF00637 | |
| Domain | CHCR | 2.79e-04 | 7 | 69 | 2 | PS50236 | |
| Domain | Clathrin_H-chain/VPS_repeat | 3.71e-04 | 8 | 69 | 2 | IPR000547 | |
| Domain | Pyridoxal_deC | 3.71e-04 | 8 | 69 | 2 | PF00282 | |
| Domain | DDC_GAD_HDC_YDC | 3.71e-04 | 8 | 69 | 2 | PS00392 | |
| Domain | PyrdxlP-dep_de-COase | 3.71e-04 | 8 | 69 | 2 | IPR002129 | |
| Domain | E3_UB_ligase_RBR | 5.94e-04 | 10 | 69 | 2 | IPR031127 | |
| Domain | IBR | 1.19e-03 | 14 | 69 | 2 | SM00647 | |
| Domain | ATPase_dyneun-rel_AAA | 1.19e-03 | 14 | 69 | 2 | IPR011704 | |
| Domain | IBR | 1.19e-03 | 14 | 69 | 2 | PF01485 | |
| Domain | AAA_5 | 1.19e-03 | 14 | 69 | 2 | PF07728 | |
| Domain | IBR_dom | 1.37e-03 | 15 | 69 | 2 | IPR002867 | |
| Domain | - | 7.23e-03 | 207 | 69 | 4 | 1.25.40.10 | |
| Domain | - | 7.40e-03 | 35 | 69 | 2 | 3.90.1150.10 | |
| Pathway | REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS | 1.18e-04 | 5 | 49 | 2 | M27300 | |
| Pathway | REACTOME_MUSCARINIC_ACETYLCHOLINE_RECEPTORS | 1.18e-04 | 5 | 49 | 2 | MM15006 | |
| Pubmed | The clathrin heavy chain isoform CHC22 functions in a novel endosomal sorting step. | 4.23e-06 | 2 | 72 | 2 | 20065094 | |
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 8733129 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17586055 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 16877267 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 29097553 | ||
| Pubmed | 4.23e-06 | 2 | 72 | 2 | 17286988 | ||
| Pubmed | Pharmacogenetics of antipsychotic response in the CATIE trial: a candidate gene analysis. | 4.82e-06 | 118 | 72 | 5 | 19156168 | |
| Pubmed | Functional equivalence of the clathrin heavy chains CHC17 and CHC22 in endocytosis and mitosis. | 1.27e-05 | 3 | 72 | 2 | 19509056 | |
| Pubmed | Muscarinic acetylcholine receptor subtypes as agonist-dependent oncogenes. | 1.27e-05 | 3 | 72 | 2 | 1905013 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 8499653 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 15133132 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 16956767 | ||
| Pubmed | Clathrin promotes centrosome integrity in early mitosis through stabilization of centrosomal ch-TOG. | 1.27e-05 | 3 | 72 | 2 | 22891263 | |
| Pubmed | M1 receptors mediate cholinergic modulation of excitability in neocortical pyramidal neurons. | 1.27e-05 | 3 | 72 | 2 | 19657040 | |
| Pubmed | Muscarinic cholinergic receptor (M2) plays a crucial role in the development of myopia in mice. | 1.27e-05 | 3 | 72 | 2 | 23649821 | |
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 15146045 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 15691866 | ||
| Pubmed | 1.27e-05 | 3 | 72 | 2 | 21335473 | ||
| Pubmed | Ciliary activity in the oviduct of cycling, pregnant, and muscarinic receptor knockout mice. | 2.53e-05 | 4 | 72 | 2 | 22302687 | |
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 8063729 | ||
| Pubmed | 2.53e-05 | 4 | 72 | 2 | 11855742 | ||
| Pubmed | HIP1 functions in clathrin-mediated endocytosis through binding to clathrin and adaptor protein 2. | 2.53e-05 | 4 | 72 | 2 | 11517213 | |
| Pubmed | KSR1 CLTCL1 MDN1 AGO4 ALDH16A1 MPDU1 CLTC GEMIN5 XPO1 PEX11B TMBIM6 | 2.71e-05 | 1168 | 72 | 11 | 19946888 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | USP34 ZNF473 MPDU1 CLTC NOC3L GEMIN5 XPO1 TNFRSF10B PEX11B INTS3 ZFPL1 | 3.54e-05 | 1203 | 72 | 11 | 29180619 |
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 24695732 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 20940295 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 7648406 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 26084221 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 15574798 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 15919709 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 12675128 | ||
| Pubmed | Regulation of CD8+ cytolytic T lymphocyte differentiation by a cholinergic pathway. | 4.21e-05 | 5 | 72 | 2 | 15913791 | |
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 10436022 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 11306684 | ||
| Pubmed | Muscarinic acetylcholine receptor subtypes: localization and structure/function. | 4.21e-05 | 5 | 72 | 2 | 8248499 | |
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 30914695 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 12151512 | ||
| Pubmed | Muscarinic receptors 2 and 5 regulate bitter response of urethral brush cells via negative feedback. | 4.21e-05 | 5 | 72 | 2 | 29401598 | |
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 15661360 | ||
| Pubmed | Muscarinic receptor subtypes in cilia-driven transport and airway epithelial development. | 4.21e-05 | 5 | 72 | 2 | 19213795 | |
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 18755247 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 20463237 | ||
| Pubmed | 4.21e-05 | 5 | 72 | 2 | 19940190 | ||
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 31914675 | ||
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 19182865 | ||
| Pubmed | Expression of GAD67 and Dlx5 in the taste buds of mice genetically lacking Mash1. | 6.31e-05 | 6 | 72 | 2 | 24682237 | |
| Pubmed | 6.31e-05 | 6 | 72 | 2 | 25107909 | ||
| Pubmed | A role for the CHC22 clathrin heavy-chain isoform in human glucose metabolism. | 8.82e-05 | 7 | 72 | 2 | 19478182 | |
| Pubmed | Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell surface receptor. | 8.82e-05 | 7 | 72 | 2 | 16314522 | |
| Pubmed | 8.82e-05 | 7 | 72 | 2 | 35427599 | ||
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | 1.20e-04 | 719 | 72 | 8 | 35337019 | |
| Pubmed | 1.31e-04 | 376 | 72 | 6 | 24154525 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 1.40e-04 | 942 | 72 | 9 | 31073040 | |
| Pubmed | 1.51e-04 | 9 | 72 | 2 | 24292102 | ||
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 1.57e-04 | 130 | 72 | 4 | 19874574 | |
| Pubmed | 1.88e-04 | 10 | 72 | 2 | 25898166 | ||
| Pubmed | 1.88e-04 | 10 | 72 | 2 | 10336173 | ||
| Pubmed | 2.30e-04 | 11 | 72 | 2 | 29604273 | ||
| Pubmed | 2.57e-04 | 272 | 72 | 5 | 31010829 | ||
| Pubmed | Enlarged dendritic spines and pronounced neophobia in mice lacking the PSD protein RICH2. | 2.75e-04 | 12 | 72 | 2 | 26969129 | |
| Pubmed | Glutamatergic gene variants impact the clinical profile of efficacy and side effects of haloperidol. | 3.25e-04 | 13 | 72 | 2 | 20859245 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ZDHHC21 USP34 MDN1 SEC23IP UGCG ANKIB1 LRRN2 TNFRSF10B ZFPL1 | 3.36e-04 | 1061 | 72 | 9 | 33845483 |
| Pubmed | 3.55e-04 | 638 | 72 | 7 | 31182584 | ||
| Pubmed | 3.78e-04 | 14 | 72 | 2 | 29361518 | ||
| Pubmed | 3.78e-04 | 14 | 72 | 2 | 34995116 | ||
| Pubmed | 4.03e-04 | 300 | 72 | 5 | 19086053 | ||
| Pubmed | 4.08e-04 | 653 | 72 | 7 | 22586326 | ||
| Pubmed | 4.36e-04 | 15 | 72 | 2 | 19944766 | ||
| Pubmed | 4.36e-04 | 15 | 72 | 2 | 19762545 | ||
| Pubmed | 4.36e-04 | 15 | 72 | 2 | 17400507 | ||
| Pubmed | 5.06e-04 | 484 | 72 | 6 | 31995728 | ||
| Pubmed | Mapping of five subtype genes for muscarinic acetylcholine receptor to mouse chromosomes. | 5.63e-04 | 17 | 72 | 2 | 10549128 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 6.38e-04 | 332 | 72 | 5 | 32786267 | |
| Pubmed | No evidence for association between 19 cholinergic genes and bipolar disorder. | 7.06e-04 | 19 | 72 | 2 | 17373692 | |
| Pubmed | 7.06e-04 | 19 | 72 | 2 | 18329113 | ||
| Pubmed | 7.44e-04 | 1440 | 72 | 10 | 30833792 | ||
| Pubmed | 7.60e-04 | 197 | 72 | 4 | 31620119 | ||
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 8.35e-04 | 202 | 72 | 4 | 33005030 | |
| Pubmed | 8.35e-04 | 202 | 72 | 4 | 24639526 | ||
| Pubmed | Subtype specification of GABAergic amacrine cells by the orphan nuclear receptor Nr4a2/Nurr1. | 8.65e-04 | 21 | 72 | 2 | 19692620 | |
| Pubmed | 8.65e-04 | 21 | 72 | 2 | 15452121 | ||
| Pubmed | 1.04e-03 | 23 | 72 | 2 | 19549527 | ||
| Pubmed | 1.08e-03 | 560 | 72 | 6 | 35241646 | ||
| Pubmed | 1.13e-03 | 777 | 72 | 7 | 35844135 | ||
| Pubmed | Systematic Analysis of Human Protein Phosphatase Interactions and Dynamics. | 1.21e-03 | 573 | 72 | 6 | 28330616 | |
| Pubmed | PPP4R1 USP34 LIMK1 ZNF473 SEC23IP CLTC LRRN2 CDC42BPB TARBP1 | 1.31e-03 | 1285 | 72 | 9 | 35914814 | |
| Pubmed | 1.33e-03 | 26 | 72 | 2 | 24067654 | ||
| Pubmed | 1.43e-03 | 27 | 72 | 2 | 20080794 | ||
| Pubmed | 1.46e-03 | 235 | 72 | 4 | 32614325 | ||
| Pubmed | 1.50e-03 | 237 | 72 | 4 | 29564676 | ||
| Pubmed | TRRAP is essential for regulating the accumulation of mutant and wild-type p53 in lymphoma. | 1.54e-03 | 28 | 72 | 2 | 29653964 | |
| Pubmed | Satb2 regulates the development of dopaminergic neurons in the arcuate nucleus by Dlx1. | 1.54e-03 | 28 | 72 | 2 | 34564702 | |
| Pubmed | Autophagy negatively regulates cancer cell proliferation via selectively targeting VPRBP. | 1.77e-03 | 30 | 72 | 2 | 22963397 | |
| Pubmed | 1.89e-03 | 31 | 72 | 2 | 32499648 | ||
| Pubmed | SARS-CoV-2 NSP12 associates with TRiC and the P323L substitution acts as a host adaption. | 2.01e-03 | 120 | 72 | 3 | 37929963 | |
| Cytoband | 11q13 | 8.67e-04 | 118 | 72 | 3 | 11q13 | |
| Cytoband | 2p15 | 1.10e-03 | 31 | 72 | 2 | 2p15 | |
| GeneFamily | Cholinergic receptors muscarinic | 7.76e-05 | 5 | 51 | 2 | 180 | |
| ToppCell | Cerebellum-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pvalb|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 4.36e-06 | 149 | 72 | 5 | 6e9ca280a599d96f8956ef26f2a46b9484de5488 | |
| ToppCell | LPS-IL1RA+antiTNF-Unknown-Endothelial-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.12e-06 | 154 | 72 | 5 | 16fdafb5c64d2db321554f87129a962d113f1668 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.04e-06 | 169 | 72 | 5 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.04e-06 | 169 | 72 | 5 | 335619507857383c3b0b507cdf05d786ed59e585 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.79e-06 | 176 | 72 | 5 | 682a1dfcc507ec540f5fadf08e872533ea9f0291 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.03e-05 | 178 | 72 | 5 | 6ad46b0720298bcb927fd53468bb4ea0c199ad35 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.06e-05 | 179 | 72 | 5 | d1365d48d1b017a7917f4f63a82ac4720c3d87df | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.09e-05 | 180 | 72 | 5 | 8f774dcacc1626e4e6492f1eb927b0ed56fbe686 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.12e-05 | 181 | 72 | 5 | bd7e9437839bca543ca5945df43d6525e6a312a8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-05 | 182 | 72 | 5 | 08aff7112c9dac0ef5540300516a604782b21169 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 186 | 72 | 5 | 948815663c212c4311329d503b5991cbbbff9808 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.28e-05 | 186 | 72 | 5 | 6379609b7ace80683f5754b16aa77f11b43766ae | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.31e-05 | 187 | 72 | 5 | d413fb4b1531b297af5012a392b88128510c2de8 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 188 | 72 | 5 | 72cbfe9dc0583dbeafa6cb0945fa370d0c808284 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.35e-05 | 188 | 72 | 5 | 8de5a07301f9b5984680c873e5a92395b5ed3dd3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.38e-05 | 189 | 72 | 5 | 78cf414b98bcb19deb934409acddaad1cd51b67f | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.42e-05 | 190 | 72 | 5 | 3f22c118d552345f731d4d49f0bcb5765d93de3b | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.49e-05 | 192 | 72 | 5 | 0003d7ef9a8e521e70ac33c63aad843d9b6215c2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.53e-05 | 193 | 72 | 5 | c4b22b62f3cc7bf0ec0eba76e1504c236290bbc9 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Papillary_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 7.21e-05 | 137 | 72 | 4 | 2a5d2a99a2c532480d00b80a4885514a8a5c80fa | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6-Excitatory_Neuron.Slc17a7.Bcl6-Tshz2-Syt2_(Layer_5a,_Entorhinal_cortex,_Tshz1+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 7.74e-05 | 51 | 72 | 3 | adc73d6909d75ad432aef884dae540b7e48cecd6 | |
| ToppCell | 10x5'-Lung-Lymphocytic_T_CD4-T_CD4/CD8|Lung / Manually curated celltypes from each tissue | 1.19e-04 | 156 | 72 | 4 | 10d191e29b16cae8238e8df6c0ff38882253f34e | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Myh8_Fibin|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.22e-04 | 157 | 72 | 4 | 741d79c10cb87fa7f14080c6fccb1553c3a20bad | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.22e-04 | 157 | 72 | 4 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Epithelial-neuro-epithelial-EECs|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 165 | 72 | 4 | 4b4e75ad0eb0a6b00c30a000ec6267e23ba2e496 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.51e-04 | 166 | 72 | 4 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L6_LHX6_GLP1R|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-04 | 168 | 72 | 4 | 2eed7dc1a2aff11be024823c4323c42bc94362f6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 169 | 72 | 4 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.62e-04 | 169 | 72 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.66e-04 | 170 | 72 | 4 | d70aaa0f4e5034bb9f61b832b5f9123870936d3c | |
| ToppCell | 11.5-Airway-Epithelial-Basal_cell|Airway / Age, Tissue, Lineage and Cell class | 1.73e-04 | 172 | 72 | 4 | 9d4d92e2d16dfc8a394f2641653bb97de20a2530 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.77e-04 | 173 | 72 | 4 | efb8072475000888efe088d00e870c56ffad4172 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 174 | 72 | 4 | a8bd1fa08bf061a627529a38e5a23a68b6d80697 | |
| ToppCell | facs-Lung-EPCAM-3m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.81e-04 | 174 | 72 | 4 | 7f8f6a15a823809effd37c1a5b09ef19b6d67755 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.81e-04 | 174 | 72 | 4 | 58300d64d3b6fd9ba1b6c87ea83b2777eb6be2f4 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.85e-04 | 175 | 72 | 4 | 9d797888edb39fd12fd9cfc698a42b7bed19a5b5 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD8_T-CD8_T_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-04 | 175 | 72 | 4 | 8958c5c30437d20a4abd70d7527990f7e2a68b93 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 177 | 72 | 4 | 7c3d46ebd7e8726be6871aa9763e281fc0ec6ac8 | |
| ToppCell | facs-Heart-RV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.93e-04 | 177 | 72 | 4 | e7b1f3092e6b8d0d580f82648035f5ad12be6961 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.93e-04 | 177 | 72 | 4 | 91706bd0d4dda8d98843fb00b898d5aca4d66b64 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.98e-04 | 178 | 72 | 4 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | RSV-Healthy-0|RSV / Virus stimulation, Condition and Cluster | 2.06e-04 | 180 | 72 | 4 | 974044056e2f7e909cb11c6f6ca89e58bf95f7e5 | |
| ToppCell | RSV-Healthy-0|Healthy / Virus stimulation, Condition and Cluster | 2.06e-04 | 180 | 72 | 4 | 703a1d0f9536af94d56757eb01221878d7b7fe61 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_FAM150B|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.11e-04 | 181 | 72 | 4 | af92b8b7f455210dab502ef6964f3a0162180759 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-ciliated_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.11e-04 | 181 | 72 | 4 | dfce05bd472f67e6e2bb60ebd6fd34f0a9aeeca6 | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 2.15e-04 | 182 | 72 | 4 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-04 | 182 | 72 | 4 | a3c5c0eff527c8d3848acda14af8f9e99c69b0de | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-04 | 182 | 72 | 4 | 1923932a9c60e9ec33db69ded441210d1fb07bec | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 2.15e-04 | 182 | 72 | 4 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.15e-04 | 182 | 72 | 4 | 69ff652f74cc47fbe0bd665ab17c445c5b959dad | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5_PVALB_CNTNAP3P2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 183 | 72 | 4 | 121791ef84e7ce377ed6f5b7953af8865e04958e | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L3-4_PVALB_HOMER3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 183 | 72 | 4 | d2074b13b4831ec18c81273d9a1ff673c3f6a16d | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.20e-04 | 183 | 72 | 4 | 04d3cc76038b8192c915f1c08c3e26f2ad3b3779 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.24e-04 | 184 | 72 | 4 | 2ba98708dfd7f1b2a661578a334684094ff453ad | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 2.29e-04 | 185 | 72 | 4 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L5-6_PVALB_STON2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.29e-04 | 185 | 72 | 4 | f4ac62009c0ad3346e71b809e17727303c4df153 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D231|Adult / Lineage, Cell type, age group and donor | 2.43e-04 | 188 | 72 | 4 | 34b11f72ca73153d02edcd09b38983ad1a504659 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 189 | 72 | 4 | 222e67d3fd106c43b0cae6538dddeaa7be1f759f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-04 | 189 | 72 | 4 | 99a13b1b669b0cd36e3096632351d9ade25d1173 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 2.48e-04 | 189 | 72 | 4 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | COVID-19-lung-Ciliated|lung / Disease (COVID-19 only), tissue and cell type | 2.48e-04 | 189 | 72 | 4 | 27329c4661aebabd19fac7fe5dca263fe99d76f3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-04 | 190 | 72 | 4 | 26843ec1d19ac85a50990705353b802745d33e4d | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-04 | 190 | 72 | 4 | 305fbef734c350cfbf786ca7ff6e07093aab56ea | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-04 | 190 | 72 | 4 | 39ab890104b4264c68a968f920f4ccd84f0bc681 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-04 | 190 | 72 | 4 | 8c9c230a509afaeee50644153974a5642b01a2b8 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-04 | 190 | 72 | 4 | 0acf1d5da68db449d8c9e70519a236ce825f9d11 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.53e-04 | 190 | 72 | 4 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-04 | 191 | 72 | 4 | e417bf491f8b8d7838a61f7f4f6b1740ba97aa3f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.58e-04 | 191 | 72 | 4 | 08720998aa55131d7377c4c67c4c935865bd7d79 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-04 | 191 | 72 | 4 | 9d31c8424d35bdc0c27188b68bfd0f731af3600b | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L2-4_SST_AHR|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 191 | 72 | 4 | 782bc7946417549ffd39e5b596db659436fa01ba | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L1_LAMP5_NDNF|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.58e-04 | 191 | 72 | 4 | 7b386512284dfaa0e95358b28ee82632ee965e64 | |
| ToppCell | nucseq-Epithelial-Epithelial_Airway|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.58e-04 | 191 | 72 | 4 | 1c528f72c9ef3ef3a850b05e4a9715190832270c | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 192 | 72 | 4 | 38d7a24ae205ef91ed2e0f402d8022f2a9cdb243 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.64e-04 | 192 | 72 | 4 | 072281344d58e85c9a290750b488d0c101f75d54 | |
| ToppCell | LAM-Epithelial-AirwayEpi|LAM / Condition, Lineage and Cell class | 2.64e-04 | 192 | 72 | 4 | 7404fc65be3b7bd09447725b43fa31819004dfee | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 192 | 72 | 4 | 84149a5c6c3b3c9b86aed77cf8e72d99ef099fab | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-04 | 192 | 72 | 4 | 67d6230e32d446dcb12047fae2c3f1faa80dd720 | |
| ToppCell | droplet-Kidney-nan-18m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.64e-04 | 192 | 72 | 4 | 04d155897ed075c359933080e36a4ab2150b6e9f | |
| ToppCell | mild-Myeloid-Immature_Neutrophils_2|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.64e-04 | 192 | 72 | 4 | 0445fdc670fa7b847dcd0a061d7736ddcf3519ba | |
| ToppCell | IPF-Epithelial-Ciliated|IPF / Disease state, Lineage and Cell class | 2.64e-04 | 192 | 72 | 4 | 354adc1354bf596fbc60dd45c0169688e6f45165 | |
| ToppCell | control-Myeloid-Immature_Neutrophils_2|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.69e-04 | 193 | 72 | 4 | 33349830e9eba506470ad3661fad5e5a283d20ca | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_3|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.69e-04 | 193 | 72 | 4 | 4979862c0c16e6b4baa4c79894f1d237c861f5a5 | |
| ToppCell | LAM-Epithelial-AirwayEpi|Epithelial / Condition, Lineage and Cell class | 2.69e-04 | 193 | 72 | 4 | f2672d2c495ee12c3b7d132452bde581fa5a7856 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-04 | 194 | 72 | 4 | 4f758718a1233c25c25d99fc1b7b06f906b8b0a2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.74e-04 | 194 | 72 | 4 | 02a9cc821c2b14aa7d0e55661a5fab66364474e1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.80e-04 | 195 | 72 | 4 | 79dc031258579ea328181dda33710dd897f1064a | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_cell|Airway / Age, Tissue, Lineage and Cell class | 2.80e-04 | 195 | 72 | 4 | 3441381759cd00d125752401dc99b78be1c78f88 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.91e-04 | 197 | 72 | 4 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|Endothelial / Disease state, Lineage and Cell class | 2.96e-04 | 198 | 72 | 4 | b8bd1ba268480f54451648e01631b615a3401144 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.96e-04 | 198 | 72 | 4 | 844f534551483c89ef789d1cfeb4680e54f794b2 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_2|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.96e-04 | 198 | 72 | 4 | e36303628af3139310c1d7a84d2919b7319bbda4 | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-immature_Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 3.02e-04 | 199 | 72 | 4 | e222b90caf45904d8f763574e7b6aac13333df92 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | e79d93d55b25804f2608185168da472301b6ebca | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2--L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | 3cbb01039d1e7635ec4dcdf0223587f7ea3c7b34 | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)-SULF1--L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | 4a426ef88376d8bb2b9dc50aa06e7b9fc50ecc9c | |
| ToppCell | Neuronal-Inhibitory-iB-iB_2(PVALB)|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | 1276bfa911fddada4235e12e3081baa53164574b | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-MIR548F2-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | 97a010a1b6d551239cf6ea5a43319fb413ff180e | |
| ToppCell | Neuronal-Inhibitory-iB-iB_3(PVALB-SST)-FRZB--L2-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.08e-04 | 200 | 72 | 4 | 5ec469267747dce3601c1d8ad01af89fa5b29acc | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.08e-04 | 200 | 72 | 4 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| Drug | Badg | 9.59e-06 | 2 | 71 | 2 | CID000125951 | |
| Drug | PGW5 compound | 1.92e-05 | 17 | 71 | 3 | ctd:C000593032 | |
| Drug | library 2 | 2.72e-05 | 19 | 71 | 3 | CID005270634 | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.30e-05 | 195 | 71 | 6 | 6643_DN | |
| Drug | biperiden | 4.92e-05 | 23 | 71 | 3 | CID000002381 | |
| Drug | hexocyclium | 5.73e-05 | 4 | 71 | 2 | CID000024199 | |
| Drug | AC1OAR8J | 5.73e-05 | 4 | 71 | 2 | CID006834124 | |
| Drug | Botiacrine | 5.73e-05 | 4 | 71 | 2 | CID000071202 | |
| Drug | fluperlapine | 8.06e-05 | 27 | 71 | 3 | CID000049381 | |
| Drug | Atropine | 9.53e-05 | 5 | 71 | 2 | DB00572 | |
| Drug | Fesoterodine | 9.53e-05 | 5 | 71 | 2 | DB06702 | |
| Drug | Darifenacin | 9.53e-05 | 5 | 71 | 2 | DB00496 | |
| Drug | Metixene | 9.53e-05 | 5 | 71 | 2 | DB00340 | |
| Drug | Trihexyphenidyl | 9.53e-05 | 5 | 71 | 2 | DB00376 | |
| Drug | Solifenacin | 9.53e-05 | 5 | 71 | 2 | DB01591 | |
| Drug | 5-(3-(3-hydroxyphenoxy)azetidin-1-yl)-5-methyl-2,2-diphenylhexanamide | 9.53e-05 | 5 | 71 | 2 | ctd:C568516 | |
| Drug | Pipecuronium | 9.53e-05 | 5 | 71 | 2 | ctd:D017300 | |
| Drug | N-Methylscopolamine | 9.53e-05 | 5 | 71 | 2 | ctd:D019832 | |
| Drug | F 2268 | 9.53e-05 | 5 | 71 | 2 | CID000020410 | |
| Drug | eucatropine | 9.53e-05 | 5 | 71 | 2 | CID000007534 | |
| Drug | Tolterodine | 9.53e-05 | 5 | 71 | 2 | DB01036 | |
| Drug | [[2-(1,3-dimethyl-2,6-dioxo-purin-7-yl)-2-isobutyl-1,4-dimethyl-pentyl]amino] benzoate | 9.53e-05 | 5 | 71 | 2 | CID011971451 | |
| Drug | Cryptenamine | 9.53e-05 | 5 | 71 | 2 | DB00785 | |
| Drug | Homatropine Methylbromide | 9.53e-05 | 5 | 71 | 2 | DB00725 | |
| Drug | hexahydro-difenidol | 9.53e-05 | 5 | 71 | 2 | CID000124226 | |
| Drug | Quinuclidinyl Benzilate | 9.53e-05 | 5 | 71 | 2 | ctd:D011813 | |
| Drug | trihexyphenidyl | 1.35e-04 | 32 | 71 | 3 | CID000005572 | |
| Drug | Nsc34399 | 1.43e-04 | 6 | 71 | 2 | CID000003622 | |
| Drug | Gallamine Triethiodide | 1.43e-04 | 6 | 71 | 2 | ctd:D005703 | |
| Drug | Dactil | 1.43e-04 | 6 | 71 | 2 | CID000004839 | |
| Drug | 4-diphenylacetoxy-1,1-dimethylpiperidinium | 1.43e-04 | 6 | 71 | 2 | ctd:C042375 | |
| Drug | brucine N-oxide | 1.43e-04 | 6 | 71 | 2 | ctd:C083067 | |
| Drug | Brompheniramine | 1.43e-04 | 6 | 71 | 2 | DB00835 | |
| Drug | AC1L1IPS | 1.43e-04 | 6 | 71 | 2 | CID000004682 | |
| Drug | Benzquinamide | 1.43e-04 | 6 | 71 | 2 | DB00767 | |
| Drug | Scopolamine | 1.43e-04 | 6 | 71 | 2 | DB00747 | |
| Drug | Crotalid Venoms | 1.43e-04 | 6 | 71 | 2 | ctd:D003435 | |
| Disease | central nervous system disease (implicated_via_orthology) | 6.52e-04 | 16 | 70 | 2 | DOID:331 (implicated_via_orthology) | |
| Disease | Muscle hypotonia | 7.37e-04 | 17 | 70 | 2 | C0026827 | |
| Disease | antiphospholipid antibody measurement | 1.61e-03 | 25 | 70 | 2 | EFO_0005200 | |
| Disease | bipolar disorder (is_implicated_in) | 2.16e-03 | 29 | 70 | 2 | DOID:3312 (is_implicated_in) | |
| Disease | sex interaction measurement, Crohn's disease | 3.50e-03 | 37 | 70 | 2 | EFO_0000384, EFO_0008343 | |
| Disease | colon cancer (biomarker_via_orthology) | 3.88e-03 | 39 | 70 | 2 | DOID:219 (biomarker_via_orthology) | |
| Disease | Global developmental delay | 3.93e-03 | 133 | 70 | 3 | C0557874 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WNNEYILSLIEDNCH | 381 | Q15173 | |
| NCQLSEEDHWIYQAI | 256 | Q8NFR7 | |
| AWLDTQDRCLGHYVN | 31 | Q8IZ83 | |
| FFRDWDLEQQCHYEQ | 6 | P51816 | |
| DCCLAAYAFFRHIWQ | 1321 | Q8IYW2 | |
| EAYEDAANCLWLLTN | 501 | Q9P2G1 | |
| HYQVLWDDNCFTADE | 766 | Q9HCK5 | |
| HQAYRWLGLEEACQL | 111 | P50583 | |
| CNKEDIWLHVDAAYA | 261 | P20711 | |
| QCRQWDLYFEHGDAQ | 626 | O95450 | |
| CWFLAALQALALHQD | 101 | A8MX76 | |
| FAHVRYWLDCLQDAG | 921 | Q7Z6P3 | |
| FEQYCAWQLFLAHNI | 806 | Q68E01 | |
| HTFCWYCLQNLDNDI | 216 | Q7Z419 | |
| NALQHCYWKYLIVDE | 341 | Q9NRZ9 | |
| IHQQLCLNFARSLWY | 3626 | Q9NU22 | |
| FLKYWHADQLNDLCL | 1131 | Q9Y6X6 | |
| TEYWACLQVAFADAH | 591 | O75325 | |
| DICEKYNLWLHVDAA | 361 | Q99259 | |
| ALLSLLDHYEWNCFV | 141 | P48058 | |
| ENQLKLSHDWLCYLA | 766 | Q8IVT5 | |
| WCYHKNLEDLGLEFV | 1276 | Q9UHC1 | |
| LNIESANYAEHWCSL | 576 | Q02817 | |
| YFQLWNNSCLEAEHV | 126 | Q9H114 | |
| IELLRQFFDCGHWYD | 1976 | Q6ZR08 | |
| DCDFAHLFSWIQENA | 191 | Q5VT99 | |
| GDCQWITALHYAFQD | 131 | Q9Y5S2 | |
| SCLAWNSDLLYQELH | 306 | Q04756 | |
| EEDTNLWIGYCAFHL | 56 | A0AVF1 | |
| IFQLFHQCLSIHYWD | 636 | Q9H799 | |
| HWLDYGAFCLLTEDN | 671 | Q5T0N1 | |
| LACDLWLALDYVASN | 96 | P11229 | |
| CHCLAWFIFDYIQLR | 321 | Q16739 | |
| QDYIWHCIDLFLDFI | 201 | P55061 | |
| YCHSEWIIFRNAIEN | 86 | P10911 | |
| ACNVLYAFDVNTHKW | 101 | Q9BQ90 | |
| CFWCLDKYLLHLNQN | 481 | Q8N4M1 | |
| NCDFLSAAFWISLHE | 281 | Q9BRP7 | |
| LNRALYFACDNVLWA | 91 | O96011 | |
| QLENFAAFILDHRCW | 36 | Q6T423 | |
| RCYIDNLHFSGLEEW | 221 | P42702 | |
| EYCNAQNTALWELHA | 681 | Q8WTT2 | |
| CFYHNADLVSWADVI | 126 | Q6NXP6 | |
| HFWLHNLCDVYLEAV | 811 | Q5ST30 | |
| ALLDQELYNSFHFWR | 446 | Q8TF05 | |
| ALAHSREQYCLAWEA | 301 | Q5TGY1 | |
| LELAQFHCAYQLADW | 616 | Q9BYZ6 | |
| IFYANHDLSLEAALW | 346 | Q9UJ37 | |
| CWLQANLYLGLQDFD | 366 | Q9NY99 | |
| NEYLFALQSHLCYWE | 961 | Q9Y6Y8 | |
| KCYDQLFVQWDLLHV | 21 | O75352 | |
| LACDLWLALDYVASN | 101 | P08912 | |
| AAEQAHLWAELVFLY | 1351 | Q00610 | |
| AAEQAHLWAELVFLY | 1351 | P53675 | |
| LVKEALSWYDAQQHC | 26 | Q6ZU45 | |
| DCHFLQLYLWRFVAD | 731 | Q9UID3 | |
| FKICLEYWNHLAAEL | 366 | O14980 | |
| AVWQCEAGHRYFQDL | 156 | Q96CK0 | |
| DLQNLIDFAQEYWSC | 141 | Q96FV3 | |
| DYLSWRQADCHINNL | 171 | Q9NWX6 | |
| CFEDHLEQKYVQLFW | 491 | Q6ZQQ2 | |
| CYWFNRNDSQHLFIE | 136 | Q8TEQ6 | |
| QDYSTHWNDLLFCLR | 101 | O14763 | |
| WEQLLEDKHFQSYCL | 381 | Q9NNW5 | |
| NHWLFLQLCFYTELL | 131 | Q8IVQ6 | |
| DLFNFLQAHWFTCEL | 361 | Q96MP5 | |
| AQYIHDQWVCLSFLL | 886 | Q13395 | |
| DSECYDDALHWFLNQ | 1021 | Q70CQ2 | |
| ENILFLTICFCWHYA | 216 | Q9NWC5 | |
| QHVSRNFNLWACDYV | 101 | Q5VZQ5 | |
| YDLFHWACLNERAAQ | 71 | O95159 | |
| FWDTALDNCQDLFLL | 31 | Q8WTR7 | |
| QYLQALNADWHADCF | 36 | P53667 |